Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $1.80 Billion |
|---|---|
| Enterprise Value | $2.21 Billion |
| Earnings per Share | $0.2 |
| Beta | 0.46 |
| Outstanding Shares | 425,252,638 |
| P/E Ratio | 18.72 |
|---|---|
| PEG | 831.34 |
| Price to Sales | 2.26 |
| Price to Book Ratio | 2.26 |
| Enterprise Value to Revenue | 2.22 |
| Enterprise Value to EBIT | 15.76 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | 0.52 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bra...